Status:
COMPLETED
Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions:
Rheumatoid Arthritis
Cardiovascular Diseases
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
One of the greatest success stories in rheumatology - the achievement of rheumatoid arthritis (RA) remission - is tempered by the fact that individuals with RA are dramatically under evaluated and und...
Eligibility Criteria
Inclusion
- Have RA
- Age between 40 and 75 years (inclusive)
- Provide a date of their next appointment with their rheumatologist or other physician on their care team
- Willing to work with a peer coach
- Speaks English
- Have a phone
- Has access to the internet
- Resides or lives in the US
Exclusion
- Do not have rheumatoid arthritis
- Younger than age 40 or older than age 75
- Taking a statin
- No known history of diabetes
- No known history of CVD defined by:
- Open heart surgery
- Coronary angioplasty
- History of heart failure
- History of heart attack or stroke
Key Trial Info
Start Date :
January 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 6 2024
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT04488497
Start Date
January 27 2021
End Date
November 6 2024
Last Update
October 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine
New York, New York, United States, 10021